Indoor allergens associated with dust mites, pets, cockroaches, mold, and rodents are implicated in triggering asthma attacks. Approximately 32.5 million Americans have been diagnosed with asthma, and 6.2 million of these are children between 5 and 17 years of age. More than 3,000 asthma deaths occur each year. Children from disadvantaged and minority homes die from asthma attacks at a rate four times that of children from higher income families.
CarboNix LLC has raised over $1.4M in grants from various sources, including three Small Business Innovative Research (SBIR) Awards from the National Institute of Environmental Health Sciences, a component of the National Institutes of Health (NIH). The first award, for $128,748 was for a project entitled Deactivating Indoor Allergens Associated with Childhood Asthma. The second award, for $128,819, was for its project entitled Allergens and Induced Asthma: Eradicating Indoor Allergens and Dust Mites. The concepts demonstrated in the latter grant are now being extended to the pre-commercialization stage with a Phase II SBIR award in the amount of $983,497, granted in June 2014. Additional start-up funding has been provided by the SC EPSCoR/IDEA Office, as well as from SC Launch.